Novo Nordisk Foundation seeks collaborative clinical and mechanistic studies to improve female heart health
Photo credits: zverge / BigStock
The Novo Nordisk Foundation in Denmark, one of the world’s leading funders of pharmaceutical and biotechnology research, is investing €20 million in European collaborative research on sex-related differences in cardiovascular disease.
The funding will be awarded through two new grant programmes:
- The Female Heart – Clinical Research Grants have a total budget of DKK 75 million (€10 million), with up to DKK 15 million (€2 million) per project, focused on clinical medicine aimed at improving the clinical understanding of sex-related differences in cardiovascular disease.
- The
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.